#GileadNews : New Gilead and Kite Oncology data will showcase our ongoing commitment to developing differentiated approaches to help transform how cancer is treated. #ASCO24 gilead.inc/3UtJUzT

'Balance' is a word many caregivers for people with #cancer struggle to find. Laura shares her perspective and insights for those caring for both a loved one and themselves.

#KiteNews : The U.S. FDA has approved a manufacturing process change resulting in a shorter manufacturing time for our #celltherapy , which is anticipated to reduce median turnaround time from 16 to 14 days in the United States.

Read more: bit.ly/42hzUxk

Ahead of #ASH23 , hear from Kite’s Global Head of Clinical Development Frank Neumann, MD, PhD, and Global Head of Research Priti Hegde, PhD, on how far the science of cell therapy has progressed and where it is headed.